REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/20/2025
Back to search
Official data from USPTO
TULEX PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TULEX PHARMACEUTICALS
ST13
US500000086656837Class
42
Filing
86656837
Registration
5046557
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/21/2025
Trademark type
Word
Nice classes
42
Filing date
06/09/2015
Registration date
09/20/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2022
Last transaction
09/21/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/23/2016
First use in commerce
06/23/2016
Drawing code
4
Owner type
03
Owner location
Cranbury, NY
Examiner
SMITH, REBECCA
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
Tulex Pharmaceuticals Inc.
Tulex Pharmaceuticals Inc.
Representatives
Henry Shang Law Offices of Henry T. Shang
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
33 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/15/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/15/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/15/2022
E815
TEAS SECTION 8 & 15 RECEIVED
02/25/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/30/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/30/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/19/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/18/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/01/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/23/2016
IUAF
USE AMENDMENT FILED
06/26/2016
EISU
TEAS STATEMENT OF USE RECEIVED
06/26/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2015
PUBO
PUBLISHED FOR OPPOSITION
12/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/24/2015
ALIE
ASSIGNED TO LIE
10/23/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2015
DOCK
ASSIGNED TO EXAMINER
09/18/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2015
NWAP
NEW APPLICATION ENTERED
06/12/2015
Continuous trademark protection
Get notified about every new filing that threatens TULEX PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.